Founded in 2004, Evive Biotech takes a holistic approach to drug development, combining exceptional research and commercialization capabilities with world-class regulatory expertise to bring innovative therapies to market quickly and efficiently. With operations in the US, Singapore, and China, Evive Biotech strives to address unmet medical needs through partnerships with industry, physicians, and regulatory authorities to make a real and lasting difference to patients and their families worldwide.